OGEN (Oragenics Inc.) Bathi resik saben saham (EPS TTM)

Oragenics, Inc. (OGEN) management is actively attracting investment to commercialize drugs for pulmonary infections. The fundamental TTM net income per share metric on the GURU.Markets chart confirms asset movement, where the -2.21 level reflects the current magnitude. Stable FCF is supported by patents for oral medications, while growth potential is based on unique intranasal delivery of neurosteroids for CNS injuries.

OGEN (oragenics.com) riwayat Bathi resik saben siji saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 15.11.2026

Oragenics (OGEN) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Oragenics, Inc.|OGEN - Prakiraan gabungan firma investasi

- indikator valuasi pasar bisnis:

Kapitalisasi pasar Oragenics Inc.|OGEN - Nilai Wutuh Bisnis

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Oragenics|OGEN - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku oragenics.com|OGEN - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas Oragenics, Inc.|OGEN - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Oragenics Inc.|OGEN - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Oragenics, Inc.|OGEN - Utang jangka dawa|Utang jangka cendhak perusahaan Oragenics|Likuiditas cepet oragenics.com

- indikator pendapatan resik lan kelipatan nilai:

OGEN - Asil keuangan resik|Bathi sing dikarepake Oragenics, Inc.|OGEN - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Oragenics, Inc.|OGEN - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Oragenics Inc.|OGEN - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Oragenics|OGEN - Bathi resik saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan oragenics.com|OGEN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Oragenics, Inc.

- data pendapatan lan penerimaan dodolan:

OGEN - Volume dodolan perusahaan|Prakiraan volume dodolan Oragenics Inc.|OGEN - Koefisien rega marang pendapatan|Multiplikator Forward P/S Oragenics, Inc.|OGEN - Wutah pendapatan YoY sajrone 12 wulan kepungkur

Analisis fundamental perusahaan:OGEN - oragenics.com

This indicator is calculated by dividing the aggregate net income over the last four quarters by the total number of shares outstanding. The metric determines the investor's actual equity return, reflecting the efficiency of capital generation. For Oragenics, Inc. (OGEN), this calculation confirms the monetization of its unique intranasal delivery method for neuroprotectors. Inelastic demand from the military and clinics provides potential for earnings growth. By analyzing the rolling earnings per share (EPS) figure, one can assess the sustainability of this fundamental momentum.

Pesaing utama

SMMT - Bathi saben saham sajrone rolas wulan pungkasan|MRNA (Moderna) - Bathi saben saham sajrone 12 wulan pungkasan|PCVX: Bathi resik saben saham (EPS TTM)|Bathi saben siji saham sajrone 12 wulan pungkasan TARS (Tarsus Pharma)|CRMD (CorMedix Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Seres Therapeutics MCRB|Bathi resik saben saham (EPS TTM) SPRO|Bathi resik saben saham sajrone 12 wulan pungkasan Scynexis SCYX|AN2 Therapeutics - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan PYPD (PolyPid Limited)|LSB - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan Iterum Therapeutics ITRM|biomx.com (PHGE) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan BioPharma Bio (SNGX)|Bathi saben saham sajrone rolas wulan pungkasan 60 Degrees Pharmaceuticals, Inc.|Bathi saben saham sajrone 12 wulan pungkasan OPGN (OpGen Corporation)